How to Switch from Tirzepatide to Retatrutide: Protocol and Timeline

You hit the plateau. Tirzepatide worked for months, then it didn’t, and the scale stopped moving even at your max dose. Retatrutide is the natural next move for most people in that spot, but the part that stalls everyone is the same: how do you actually make the switch, and what happens to your body in the gap between the last tirz shot and the first reta one.

Short version: there’s a one-week gap, you start reta low regardless of your tirz dose, and the first few weeks feel like going backwards before they don’t. Below is the protocol, week by week, with what to expect at each stage.

The Quick Answer

Retatrutide is still in Phase 3 trials, so there is no official switching protocol. What people and their providers actually do: take your last tirzepatide dose on your normal day, wait one week (the washout), then start retatrutide at 2 mg a week no matter what tirzepatide dose you were on. Hold 2 mg for four weeks, then move to 4 mg. Some providers skip the gap week and accept a rougher first week. Hunger comes back during the gap and the first two weeks. Most people feel reta match their old tirz effect around 4 mg and pass it at 6 to 8 mg.

Regimen is a GLP-1 tracker app that keeps your dose history through the switch instead of starting over.

The Bottom Line

Switching from tirzepatide (“tirz”) to retatrutide (“reta”) is the most common GLP-1 upgrade path - typically triggered by a weight loss plateau on tirzepatide. The protocol: take your last tirzepatide dose, wait one week as a gap, then start retatrutide at 2mg/week regardless of your previous tirzepatide dose. The glucagon receptor in retatrutide is pharmacologically new to your body, so the tolerance-building phase cannot be skipped. Most users report breaking through their tirzepatide plateau within 2-3 weeks of starting retatrutide, with the return of strong appetite suppression plus noticeable increases in body heat and metabolic rate. Track your transition with the Regimen app to log doses, weight, and side effects across both compounds.

Not sure which app to use through the switch? See our pick of the best GLP-1 tracker app for logging doses, sites, and side effects across both compounds.

How to Switch from Tirzepatide to Retatrutide: The Step-by-Step Process

Switching from tirzepatide to retatrutide is something a growing number of people in the GLP-1 community are doing in 2026. The transition isn’t complicated, but doing it right matters: managing the gap, adjusting dose, and avoiding the rebound hunger that hits when you taper off one compound before fully on-ramping the other.

Here’s the process most people follow, broken into the decisions and steps that actually matter.

Step 1: Decide your timing. Most people transition at a natural decision point: end of a vial, end of a maintenance month, or after a planned break. There’s no medical reason it has to be one or the other. The question is when works for your schedule.

Step 2: Plan your gap (or skip it). Tirzepatide has a half-life of about 5 days, and after months of weekly shots it has built up, so a single week off does not clear it. Reckon on about three weeks to fall to roughly a tenth of a dose and about a month to be essentially clear. Some people wait 1-2 weeks before starting retatrutide to let levels drop, reducing the chance of compound stacking and side effects. Others switch immediately and ramp retatrutide low. Both approaches are common in the community. Talk to your prescribing doctor about which makes sense for you.

Step 3: Start retatrutide at a conservative dose. Even if you were on a high tirzepatide dose, the community pattern is to start retatrutide at the lower trial doses (2mg or 4mg weekly). The compounds are similar but not identical, and your body adjusts. Going up gradually is easier than coming down from too much.

Step 4: Watch for rebound hunger and food noise. The most common report from people switching: hunger and food noise return for a week or two before retatrutide takes full effect. This is the gap between tirzepatide clearing and retatrutide saturating. Plan for it. Don’t panic.

Step 5: Track your protocol carefully during the transition. This is exactly when tracking matters most. Dose dates, side effects, weight, hunger ratings, and any blood work all become more useful when you’re dialing in a new protocol.

Switching from Tirzepatide to Retatrutide: What the Clinical Trial Data Shows

The TRIUMPH and ATTAIN clinical trials for retatrutide (Eli Lilly) used the standard sequential approach: patients on prior GLP-1 therapy washed out before enrolling. The trial data doesn’t directly cover compound-to-compound switching, but it does establish baseline tolerability:

• Retatrutide trial doses ranged from 1mg to 12mg weekly, with most maintenance protocols landing at 8-12mg.
• Tirzepatide maintenance is typically 10-15mg weekly.
• The dose ranges are similar, but the compounds bind different receptors. Tirzepatide is a GIP/GLP-1 dual agonist; retatrutide is a GIP/GLP-1/glucagon triple agonist. The third pathway is what differentiates retatrutide for fat loss specifically.

What the community is reporting in 2026: people switching from tirzepatide to retatrutide for plateau-breaking are seeing weight loss resumption within 4-8 weeks of the transition, but with a transition period of 1-3 weeks of return hunger and reduced compound effect.

The third pathway is what differentiates retatrutide for fat loss specifically, and what the recomp data actually shows - more total fat loss with a similar lean-mass ratio to tirzepatide when protein and training are in place.

When to Consider Switching

Should you switch from tirz to reta? Only if tirzepatide has actually stopped working for you, not because reta is the newer compound. Switching from tirzepatide to retatrutide makes sense when:

• You’ve genuinely plateaued on tirzepatide - weight loss has stalled for 4+ weeks at your maximum tolerated dose despite consistent compliance
• You’ve optimized the basics first - protein intake (1.2-1.6g/kg/day), exercise, sleep, and hydration are all dialed in. A plateau on tirz with poor diet is not a reason to switch compounds - it’s a reason to fix your diet
• You’ve tried split dosing - some tirzepatide plateaus are actually dose-timing issues. Splitting your weekly dose into 2 injections can restart weight loss without switching compounds
• You’re working with a provider - someone who can monitor labs, adjust dosing, and manage the transition medically
• You understand the trade-offs - retatrutide is not FDA-approved, has stronger side effects, costs more, and has less long-term safety data than tirzepatide

Warning

Retatrutide is in Phase 3 clinical trials and not FDA-approved. This switching guide is based on community protocols and provider experience, not randomized switching studies. Always work with a licensed healthcare provider when transitioning between GLP-1 compounds.

Do NOT switch if:

• You’ve been on tirzepatide for less than 6 months (give it time)
• You haven’t reached at least 10mg tirzepatide (you may not have hit your effective dose yet)
• Your plateau is less than 4 weeks old (normal weight fluctuations can mimic plateaus)
• You’re switching purely for faster results rather than because tirzepatide stopped working

Before You Switch: Checklist

Before your last tirzepatide dose, prepare:

What Is the Washout Period Between Tirzepatide and Retatrutide?

One week is what most people do. Last tirzepatide shot on your usual day, skip the following week, first retatrutide shot the week after that.

Here is the part nobody tells you: one week is not a real washout. Tirzepatide’s half-life is about 5 days, and after a couple of months of weekly shots you are at steady state, meaning the drug has built up to a level that never fully drops between injections. Seven days after your last dose you are sitting at roughly the same trough you hit every week anyway, right before your next shot would have been due. Getting down to almost nothing takes closer to three weeks.

So why take the week off at all? Not to clear the drug. To get a clean read. You go into your first reta shot without a fresh tirzepatide peak stacked on top, and when side effects show up you know which compound to blame.

A longer gap of two to three weeks does clear more, but you spend it with no appetite control and most people regain a few pounds. No gap at all works too, and some providers do it that way; your first reta dose just lands on a fresh tirz peak instead of a trough, and week 1 is rougher for it. Switching back the other way, reta to tirz, works the same.

The Switching Protocol (Week by Week)

Pro Tip

The gap week (Week 1) is optional but recommended. Some providers have patients start retatrutide the week after their last tirzepatide dose with no gap. Some overlap happens either way, because tirzepatide is still in you at week 1 whether you gap or not. What the gap buys is a cleaner baseline: no fresh peak on top, and side effects you can actually attribute. If you skip the gap, be extra cautious about nausea in week 1 of retatrutide - you may have residual tirzepatide activity amplifying the effect.

Switching from 7.5, 10, 12.5 or 15 mg Tirzepatide (Mounjaro or Zepbound) to Retatrutide

Your tirzepatide dose does not change your retatrutide starting dose. Everyone starts at 2 mg. What it changes is how big the step back feels in the first month, and whether you are switching from a pen or a vial.

From 5 mg or 7.5 mg tirzepatide

The smallest step down, since 2 mg of reta is not far from where you were. If you plateaued this low on tirzepatide, check the “do not switch” list above first: a 7.5 mg plateau often means you never reached your effective tirz dose. Worth knowing that SURMOUNT-1 never tested 7.5 mg, so there is no trial number for the dose you are leaving.

From 10 mg tirzepatide

Expect weeks 2 to 5 at 2 mg to feel like the gap week never ended. 2 mg is a tolerance dose, not a working one. The 4 mg tier is where appetite control comes back, and the 6 and 8 mg tiers are where people report passing where tirzepatide had them. Give it the whole ramp before you judge it.

From 12.5 mg or 15 mg tirzepatide (the max dose)

The biggest step back, and the switch people most often quit. 2 mg of reta is nowhere near 15 mg of tirz. Hunger and food noise come back in the gap week and stay through most of the 2 mg phase. This is not the switch failing; it is the ramp. Do not start at 4 or 6 mg to “match” your old dose: the glucagon receptor is new to your body and starting high is how people end up with a week of vomiting. There is no published conversion between the two compounds, so nobody can tell you which reta dose equals your old 15 mg, or when you will get there. Split dosing 1 mg twice a week from the first shot makes the ramp smoother.

If you were on Mounjaro or Zepbound pens

Same protocol, new format. The pens are fixed-dose auto-injectors: no mixing, no units. Retatrutide comes as a powder in a vial that you mix with bacteriostatic water and draw into an insulin syringe, so you will be dealing with mg/mL and syringe units for the first time. Run your vial through the retatrutide calculator before the first shot, and if the syringe markings are new to you, the insulin syringe guide covers them in five minutes. If you were on Zepbound vials you have already drawn with a syringe; the only new step is the mixing.

What to Expect During Transition

Week 1 (Gap week)

• Appetite will gradually return as tirzepatide clears your system
• You may feel hungrier than you have in months - this is normal and temporary
• Weight may tick up 1-3 lbs from increased food intake and water retention - don’t panic
• Some people feel more energetic as the GLP-1 suppression lifts

Weeks 2-3 (First retatrutide doses at 2mg)

• Mild appetite suppression returns (less than what you felt on full-dose tirzepatide)
• You may notice injection site reactions - retatrutide causes more site irritation than tirzepatide for many people, so this is the point to tighten up your injection site rotation
• Mild nausea possible but usually less than your initial tirzepatide experience
• The glucagon receptor is activating but effects are subtle at 2mg. Headaches and a flat, tired stretch are both common in these first weeks; the headache troubleshooting guide and the fatigue guide cover what usually causes each

Weeks 4-6 (Increasing to 4mg)

• Appetite suppression strengthens - most users report it matching or exceeding their peak tirzepatide effect
• Body heat increases, especially after meals - this is the glucagon receptor at work
• Some users report the “fridge doesn’t call me anymore” effect returning
• Weight loss typically restarts, often breaking through the tirzepatide plateau

Weeks 7+ (6mg and beyond)

• Full triple-agonist effect kicks in
• Weight loss accelerates beyond what tirzepatide achieved
• Side effects intensify, particularly at the 6mg to 8mg transition
• Most users who switched report being glad they did, but emphasize that the first 4-6 weeks require patience

Community Insight

The most common frustration during the switch: “I felt like I went backwards during the gap and first 2 weeks.” Your appetite returns, the scale may go up slightly, and it can feel like you’re losing progress. This is temporary. By weeks 4-6 on reta, the vast majority of users report stronger appetite suppression than they ever had on tirz, plus the added metabolic boost from the glucagon receptor. The key is trusting the process through those uncomfortable first few weeks.

Managing Side Effects During the Switch

The transition period can cause a unique mix of side effects because your body is adapting to a new receptor profile:

Pro Tip

Consider split dosing from the start of retatrutide. Instead of 2mg once per week, try 1mg twice per week. This smooths out blood levels during the critical adaptation period and reduces the nausea spike. Use the split-dose calculator to calculate exact units.

Common Mistakes When Switching

Dose Conversion: Why Everyone Starts at 2 mg

There is no direct dose conversion between tirzepatide and retatrutide. They have different receptor profiles, different potencies, and different pharmacokinetics. A person on 15mg tirzepatide does not “need” 12mg retatrutide.

The correct approach is always: start at 2mg retatrutide, titrate based on your individual response.

The two compounds have never been compared head to head, and the first direct trial is not due until the end of 2026. The only comparison anyone can honestly make is across separate trials, run for different lengths in different groups of people:

Read that as a rough map of where the doses land on a scale, not a prediction of how hungry you will feel. No trial on either compound measured appetite suppression in a way you can compare, and the reta numbers come from 24 fewer weeks of treatment. Your response is yours. Track it and adjust.

Can You Combine Tirzepatide and Retatrutide?

Maybe you’ve heard someone mention running tirz and reta at the same time. Or maybe you got there on your own: if one works and the other works, wouldn’t both together work even better? Fair question. The answer is no, and the why is worth two minutes before you talk yourself into it.

Both compounds pull the same lever. Tirzepatide works on two of your appetite receptors. Retatrutide works on those same two, plus a third one. So taking them together doesn’t add anything new. It just doubles up on receptors that are already turned all the way up. You don’t lose more weight. You just get more nausea, more dehydration, and no way to tell which one is causing what.

When people say “combine,” they usually mean one of three things. Here’s the straight answer to each.

• Taking both long-term to lose faster. Skip this one. There’s no research on taking both at once, and since they work on the same receptors, all you really stack up is the side effects, not the results.
• Overlapping them for a week while you switch. This one’s not a big deal. It really comes down to how long you wait between your last tirz shot and your first reta shot. Both stick around in your body for about 5 to 6 days, so a little overlap during the switch won’t hurt you. You just get a slightly rougher first couple of weeks.
• Going back and forth between them week to week. Some people think this gets them the best of both. What it actually does is keep your body stuck in the rough adjustment phase on retatrutide’s third receptor (the one it hasn’t gotten used to yet), over and over, so you never really settle into either one.

The bottom line: one compound, run right, beats two fighting over the same receptors. If tirzepatide has stalled out, the move is to switch over to retatrutide cleanly, not to pile it on top.

Warning

Taking two of these at the same time doubles up on the stomach side effects. It’s usually not an emergency, just days of nausea and feeling drained and dehydrated, with no way to tell which compound is doing it. If you’re switching, decide how long you’ll wait between the two and stick to it.

Tracking Your Transition

The Regimen app is built for exactly this scenario. It tracks multiple compounds on the same timeline, so you can see:

• Your last tirzepatide dose and the gap period
• Your first retatrutide dose and titration progress
• Weight trend across the entire transition
• Side effects mapped to specific dose tiers
• Blood level modeling for both compounds (see when tirz levels drop and reta levels build)

This data is invaluable for your provider visits. Instead of “I think the switch is going well,” you can show actual trends.

What We See in Regimen Data

Among Regimen users tracking GLP-1 compounds, retatrutide and tirzepatide are both commonly tracked, and plenty of people log both across a switch.

Related: Retatrutide Tracker | Tirzepatide Tracker | Tirzepatide Half-Life Calculator | GLP-1 Dose Calculator | Split Dose Calculator

Switching from Tirzepatide to Retatrutide

Many people transitioning between GLP-1 medications ask the same questions. Here’s what the data and current protocols suggest.

How long should I wait between stopping tirzepatide and starting retatrutide?

Most people wait one week, some two. Be clear about what that buys, though: after months of weekly tirzepatide you are at steady state, so seven days after your last shot you are sitting at the same trough you reach every week anyway. It is not clearance. What the gap prevents is a fresh tirzepatide peak landing on top of your first retatrutide dose. Getting to roughly a tenth of a dose takes about three weeks, and a longer gap means a longer stretch with no appetite control, which is why most people accept the overlap and start after one week.

What dose of retatrutide should I start with after tirzepatide?

Standard practice is to start at retatrutide 2mg weekly regardless of your tirzepatide dose. Retatrutide is a triple agonist (GLP-1, GIP, glucagon) and the glucagon component is novel, so even users at high tirzepatide doses (15mg) should not skip the retatrutide titration ladder. Typical schedule: 2mg, 4mg, 8mg, 12mg, increasing every 4 weeks if tolerated.

Why switch from tirzepatide to retatrutide?

The most common reasons: tirzepatide plateau (weight loss has stalled despite dose increases), dose ceiling reached (15mg is the max), or the trial numbers: retatrutide’s Phase 2 trial showed about 24% weight loss at 48 weeks on 12 mg and the Phase 3 TRIUMPH-1 trial about 28% at 80 weeks, against tirzepatide’s about 20.9% at 72 weeks on 15 mg in SURMOUNT-1. Retatrutide also includes glucagon receptor agonism which may help users who plateau due to metabolic adaptation.

Tracking your doses, weight, and symptoms through the switch is the only way to know if the timeline is working: here’s how the best peptide tracker apps handle multi-compound GLP-1 protocols.

Frequently Asked Questions